GSE112120
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (ChIP-seq data set)
To determine the binding of H3K4me1 and H3K4me3 to PCAT19 locus, we performed ChIP-seq in 22Rv1 cells. Overall design: Profiling H3K4me1 and H3K4me3 binding sites in 22Rv1 cells.